LabMinds®, Inc., a pioneer in automation for solution preparation in life sciences, today announced that the Revo has been approved for use in a Good Manufacturing Practice (GMP) certified laboratory in a Top 10 Pharmaceutical company.
LabMinds is an internationally recognized, award-winning robotics company in the pharmaceutical industry. This approval follows a 12-month product development collaboration with a European based pharmaceutical leader. GMP certification was achieved through a series of rigorous process reviews and upgrades. This GMP designation demonstrates that the Revo fulfills the high degree of quality, traceability, documentation and consistency required by the pharmaceutical industry.
“On behalf of the LabMinds team, I would like to thank everyone involved in this GMP product development project. This represents a significant milestone in our commercial growth plans to bring new products and services to market,” says Jeff Caputo, President and CEO of LabMinds. “Our customers clearly want to leverage the benefits of our Revo technology in their regulated laboratories. We look forward to launching our GMP product offering globally this year.”
